Valuation check: LHDX's profit margin is -67.41%, below the Healthcare sector average of 15.29%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2022
Trailing 12 months ending Sep 2022
The latest profit margin for LHDX is -67.41% as of September 2022. That compares with -230.42% in the prior-year period — up 70.7% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Lucira Health's historical trend and sector peers before judging valuation or financial health.
Over the past year, LHDX's profit margin moved from -230.42% to -67.41% — a 70.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lucira Health's valuation or profitability profile.
Against Healthcare companies, LHDX currently prints -67.41% for profit margin, while the sector average sits near 15.29%. That is roughly 540.8% below the sector mean. Large gaps often invite a closer look at Lucira Health's growth, margins, and balance sheet.
Profit Margin shows how effectively Lucira Health converts resources into returns. At -67.41%, LHDX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -230.42% in the prior-year period — up 70.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting LHDX's profit margin (-67.41%), review year-over-year change from -230.42%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.